Ingevity Corp (NGVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -430,300 | -5,400 | 211,600 | 118,100 | 181,400 |
| Depreciation Amortization | 457,400 | 122,800 | 108,800 | 109,900 | 100,200 |
| Income taxes - deferred | -121,400 | -44,700 | -5,000 | -4,600 | 16,200 |
| Accounts receivable | 38,200 | 42,700 | -42,100 | -13,800 | 2,800 |
| Accounts payable and accrued liabilities | -63,400 | -14,600 | 42,700 | 14,800 | 9,400 |
| Other Working Capital | -59,500 | -184,700 | -80,300 | 5,700 | 4,800 |
| Other Operating Activity | 307,600 | 289,000 | 77,700 | 63,200 | 37,600 |
| Operating Cash Flow | $128,600 | $205,100 | $313,400 | $293,300 | $352,400 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -35,300 | N/A |
| PPE Investments | -77,600 | -109,800 | -142,500 | -103,800 | -82,100 |
| Net Acquisitions | N/A | N/A | -344,500 | N/A | N/A |
| Purchase Of Investment | -300 | -2,400 | -77,400 | N/A | N/A |
| Sale Of Investment | N/A | 31,500 | N/A | N/A | N/A |
| Other Investing Activity | -1,600 | 3,400 | 12,500 | 500 | -28,500 |
| Investing Cash Flow | $-79,500 | $-77,300 | $-551,900 | $-138,600 | $-110,600 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | -1,900 | -4,400 |
| Debt Issued | 403,500 | 375,600 | 1,163,800 | -700 | 919,200 |
| Debt Repayment | -470,600 | -382,900 | -964,800 | -23,400 | -866,400 |
| Common Stock Repurchased | 0 | -92,100 | -145,200 | -109,400 | -88,000 |
| Other Financing Activity | -3,100 | -500 | -5,700 | 2,300 | -10,600 |
| Financing Cash Flow | $-70,200 | $-99,900 | $48,100 | $-133,100 | $-50,200 |
| Exchange Rate Effect | -4,200 | -300 | -6,000 | -1,700 | 2,200 |
| Beginning Cash Position | 111,900 | 84,300 | 280,700 | 260,800 | 64,600 |
| End Cash Position | 86,600 | 111,900 | 84,300 | 280,700 | 258,400 |
| Net Cash Flow | $-25,300 | $27,600 | $-196,400 | $19,900 | $193,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | 128,600 | 205,100 | 313,400 | 293,300 | 352,400 |
| Capital Expenditure | -77,600 | -109,800 | -142,500 | -103,800 | -82,100 |
| Free Cash Flow | 51,000 | 95,300 | 170,900 | 189,500 | 270,300 |